Evoke plc (LON:EVOK – Get Free Report) shares traded down 10% during mid-day trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares traded hands during mid-day trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analysts Set New Price Targets
EVOK has been the topic of several analyst reports. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a report on Monday, December 16th. Berenberg Bank dropped their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a report on Wednesday, December 4th.
View Our Latest Analysis on Evoke
Evoke Stock Performance
Evoke (LON:EVOK – Get Free Report) last announced its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. On average, equities research analysts anticipate that Evoke plc will post 12.7648305 EPS for the current fiscal year.
Insider Buying and Selling
In related news, insider Andrea Gisle Joosen purchased 14,572 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The stock was purchased at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is owned by company insiders.
Evoke Company Profile
Further Reading
- Five stocks we like better than Evoke
- What is the Euro STOXX 50 Index?
- MarketBeat Week in Review – 03/24 – 03/28
- ESG Stocks, What Investors Should Know
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How to Profit From Value Investing
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.